Base Ten Systems last week completed the sale of a convertiblesubordinated debenture that raised $10 million for the Trenton,NJ, company. Base Ten plans to use proceeds of the issue to funddevelopment and marketing of its Pharmasyst pharmaceutical
Base Ten Systems last week completed the sale of a convertible
subordinated debenture that raised $10 million for the Trenton,
NJ, company. Base Ten plans to use proceeds of the issue to fund
development and marketing of its Pharmasyst pharmaceutical manufacturing
execution system, as well as its uPACS ultrasound miniPACS archiving
product. Base Ten received 510(k) clearance for several uPACS
components in June (SCAN 7/17/96).
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.